| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus M Petri, AM Orbai, GS Alarcón, C Gordon, JT Merrill, PR Fortin, IN Bruce, ... Arthritis & Rheumatism 64 (8), 2677-2686, 2012 | 5649 | 2012 |
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop WA Wilson, AE Gharavi, T Koike, MD Lockshin, DW Branch, JC Piette, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 3518 | 1999 |
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2575 | 2002 |
| The management of thrombosis in the antiphospholipid-antibody syndrome MA Khamashta, MJ Cuadrado, F Mujic, NA Taub, BJ Hunt, GRV Hughes New England Journal of Medicine 332 (15), 993-997, 1995 | 1967 | 1995 |
| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 82 (5), 299-308, 2003 | 1792 | 2003 |
| The “primary” antiphospholipid syndrome: major clinical and serological features RA ASHERSON, MA KHAMASHTA, J Ordi-Ros, RHWM DERKSEN, ... Medicine 68 (6), 366-374, 1989 | 1391 | 1989 |
| Adult haemophagocytic syndrome M Ramos-Casals, P Brito-Zerón, A López-Guillermo, MA Khamashta, ... The Lancet 383 (9927), 1503-1516, 2014 | 1387 | 2014 |
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD SEBASTIANI, A Gil, P Lavilla, ... Medicine 72 (2), 113-124, 1993 | 1353 | 1993 |
| Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review G Ruiz-Irastorza, M Ramos-Casals, P Brito-Zeron, MA Khamashta Annals of the rheumatic diseases 69 (01), 20-28, 2010 | 1173 | 2010 |
| Antiphospholipid syndrome G Ruiz-Irastorza, M Crowther, W Branch, MA Khamashta The Lancet 376 (9751), 1498-1509, 2010 | 1114 | 2010 |
| The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation CG Skorpen, M Hoeltzenbein, A Tincani, R Fischer-Betz, E Elefant, ... Annals of the rheumatic diseases 75 (5), 795-810, 2016 | 1084 | 2016 |
| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines RA Asherson, R Cervera, PG De Groot, D Erkan, MC Boffa, JC Piette, ... Lupus 12 (7), 530-534, 2003 | 1050 | 2003 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1032 | 2008 |
| EULAR recommendations for the management of antiphospholipid syndrome in adults MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ... Annals of the rheumatic diseases 78 (10), 1296-1304, 2019 | 936 | 2019 |
| Immune-related adverse events of checkpoint inhibitors M Ramos-Casals, JR Brahmer, MK Callahan, A Flores-Chávez, N Keegan, ... Nature reviews Disease primers 6 (1), 38, 2020 | 881 | 2020 |
| Anifrolumab, an anti–interferon‐α receptor monoclonal antibody, in moderate‐to‐severe systemic lupus erythematosus R Furie, M Khamashta, JT Merrill, VP Werth, K Kalunian, P Brohawn, ... Arthritis & rheumatology 69 (2), 376-386, 2017 | 864 | 2017 |
| Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases M Ramos-Casals, P Brito-Zerón, S Muñoz, N Soria, D Galiana, ... Medicine 86 (4), 242-251, 2007 | 850 | 2007 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 840 | 2017 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 768 | 2015 |
| BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus … DA Isenberg, A Rahman, E Allen, V Farewell, M Akil, IN Bruce, D D'cruz, ... Rheumatology 44 (7), 902-906, 2005 | 707 | 2005 |
